Suven Life Sciences Limited

NSEI:SUVEN Stock Report

Market Cap: ₹28.1b

Suven Life Sciences Management

Management criteria checks 2/4

Suven Life Sciences' CEO is Venkat Jasti, appointed in Oct 2004, has a tenure of 20.08 years. directly owns 0.001% of the company’s shares, worth ₹283.36K. The average tenure of the management team and the board of directors is 14.2 years and 10.5 years respectively.

Key information

Venkat Jasti

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure20.1yrs
CEO ownership0.001%
Management average tenure14.2yrs
Board average tenure10.5yrs

Recent management updates

Recent updates

Suven Life Sciences (NSE:SUVEN) Is In A Good Position To Deliver On Growth Plans

Oct 26
Suven Life Sciences (NSE:SUVEN) Is In A Good Position To Deliver On Growth Plans

Companies Like Suven Life Sciences (NSE:SUVEN) Are In A Position To Invest In Growth

Jun 21
Companies Like Suven Life Sciences (NSE:SUVEN) Are In A Position To Invest In Growth

How Much Did Suven Life Sciences'(NSE:SUVEN) Shareholders Earn From Share Price Movements Over The Last Year?

Aug 26
How Much Did Suven Life Sciences'(NSE:SUVEN) Shareholders Earn From Share Price Movements Over The Last Year?

CEO Compensation Analysis

How has Venkat Jasti's remuneration changed compared to Suven Life Sciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-₹1b

Jun 30 2024n/an/a

-₹1b

Mar 31 2024n/an/a

-₹1b

Dec 31 2023n/an/a

-₹1b

Sep 30 2023n/an/a

-₹1b

Jun 30 2023n/an/a

-₹1b

Mar 31 2023n/an/a

-₹1b

Dec 31 2022n/an/a

-₹1b

Sep 30 2022n/an/a

-₹940m

Jun 30 2022n/an/a

-₹991m

Mar 31 2022n/an/a

-₹1b

Dec 31 2021n/an/a

-₹1b

Sep 30 2021n/an/a

-₹1b

Jun 30 2021n/an/a

-₹1b

Mar 31 2021n/an/a

-₹722m

Dec 31 2020n/an/a

-₹761m

Sep 30 2020n/an/a

-₹745m

Jun 30 2020n/an/a

-₹787m

Mar 31 2020n/an/a

-₹942m

Dec 31 2019n/an/a

₹28m

Sep 30 2019n/an/a

₹1b

Jun 30 2019n/an/a

₹871m

Mar 31 2019₹58m₹29m

-₹239m

Mar 31 2018₹47m₹25m

₹1b

Compensation vs Market: Insufficient data to establish whether Venkat's total compensation is reasonable compared to companies of similar size in the Indian market.

Compensation vs Earnings: Venkat's compensation has increased whilst the company is unprofitable.

CEO

Venkat Jasti (75 yo)

20.1yrs

Tenure

Mr. Venkateswarlu Jasti, also known as Venkat, M.Pharm. M.S., has been the Managing Director and Executive Chairman of the Board of Suven Life Sciences Limited since November 01, 2024. He is Member of Advi...

Leadership Team

NamePositionTenureCompensationOwnership
Venkateswarlu Jasti
CEO, MD & Executive Chairman20.1yrsno data0.0010%
₹ 283.4k
Sudharani Jasti
Whole-Time Director35.7yrs₹9.99m0.70%
₹ 196.6m
M. Kumar
Chief Financial Officer4.8yrsno datano data
Kundan Jha
Company Secretary & Compliance Officerless than a yearno datano data
Kalyani Jasti
President of US Operations14.2yrsno data0.00046%
₹ 129.1k

14.2yrs

Average Tenure

70yo

Average Age

Experienced Management: SUVEN's management team is seasoned and experienced (14.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Venkateswarlu Jasti
CEO, MD & Executive Chairman35.7yrsno data0.0010%
₹ 283.4k
Sudharani Jasti
Whole-Time Director35.7yrs₹9.99m0.70%
₹ 196.6m
Seyed Hasnain
Non-Independent & Non-Executive Director14.6yrs₹200.00kno data
Santanu Mukherjee
Independent Non-Executive Director6.5yrs₹250.00kno data
Jasthi Ananthasai Padmaja
Independent Non-Executive Director6yrs₹110.00kno data
Vajja Rao
Independent Directorless than a yearno datano data

10.5yrs

Average Tenure

70yo

Average Age

Experienced Board: SUVEN's board of directors are seasoned and experienced ( 10.5 years average tenure).